1. Acknowledgement to Referees

   Acknowledgement to Referees Open access 17 November 2022 Pages: 255 - 256

2. Novel Strategies for the Treatment of COVID-19

   • Matthew W. McCarthy

   Current Opinion Open access 24 August 2022 Pages: 257 - 262

3. Risk Factors for Septic Shock After Irinotecan-Containing Chemotherapy: An Exploratory Case-Control Study

   • Maki Umemiya
   • Yoshihide Inayama
   • Kenzo Kosaka

   Original Research Article Open access 20 August 2022 Pages: 263 - 269

   

4. Quercetin Supplement to Aspirin Attenuates Lipopolysaccharide-Induced Pre-eclampsia-Like Impairments in Rats Through the NLRP3 Inflammasome

   • Shuangyan Yang
   • Junfeng Zhang
   • Lili Song

   Original Research Article Open access 22 September 2022 Pages: 271 - 279

   

5. Impact of Renal Function on Anti-factor Xa Activity Concentrations with Edoxaban Use in Patients with Non-valvular Atrial Fibrillation

   • Ryohei Ono
   • Kazutaka Nishimura
   • Yoshio Kobayashi

   Original Research Article Open access 14 September 2022 Pages: 281 - 288

   

6. Clinical Validation of the Covariates Pharmacokinetic Model for Propofol in an Adult Population

   • Christopher Hawthorne
   • Martin Shaw
   • Stefan Schraag

   Original Research Article Open access 07 October 2022 Pages: 289 - 300

   

7. Chinese- and French-Manufactured Immediate-Release Glucophage^® Bioequivalence: A Randomized, Open-Label, Crossover Study

   • Chaoying Hu
   • Dan Gao
   • Lan Zhang

   Original Research Article Open access 20 October 2022 Pages: 301 - 309

   

8. Pharmacokinetics, Bioequivalence and Safety of Cloperastine in Chinese Healthy Subjects Under Fasting and Postprandial Conditions

   • Hong-Yu Luo
   • Hui-Zhi Long
   • Li-Chen Gao

   Original Research Article Open access 11 November 2022 Pages: 311 - 320